Press Releases
- RG-125 (AZD4076), a microRNA Therapeutic Targeting microRNA-103/107 for the Treatment of NASH in Patients with Type 2 Diabetes/Pre-Diabetes, Selected as Clinical Candidate by AstraZeneca
- VBI Vaccines Announces Research Collaboration With Sanofi Pasteur to Enhance Vaccine Stability
- VAXESS TECHNOLOGIES AWARDED NSF AND NIH GRANTS FOR DEVELOPMENT OF INNOVATIVE SILK PROTEIN TECHNOLOGY
- Origin of cancer wasting identified in fruit flies
- Protea Announces Agreement to Acquire vivoPharm
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.

